Claims
- 1. A method for assessing a joint of a patient, the method comprising:
(a) taking at least one three-dimensional image of the joint; (b) identifying at least one biomarker in the at least one three-dimensional image; (c) deriving at least one quantitative measurement of the at least one biomarkers; and (d) storing an identification of the at least one biomarker and the at least one quantitative measurement in a storage medium.
- 2. The method of claim 1, wherein step (d) comprises storing the at least one three-dimensional image in the storage medium.
- 3. The method of claim 1, wherein step (b) comprises statistical segmentation of the at least one three-dimensional image to identify the at least one biomarker.
- 4. The method of claim 1, wherein the at least one three-dimensional image comprises a plurality of three-dimensional images of the joint taken over time.
- 5. The method of claim 4, wherein step (b) comprises statistical segmentation of a three-dimensional image selected from the plurality of three-dimensional images to identify the at least one biomarker.
- 6. The method of claim 5, wherein step (b) further comprises motion tracking and estimation to identify the at least one biomarker in the plurality of three-dimensional images in accordance with the at least one biomarker identified in the selected three-dimensional image.
- 7. The method of claim 6, wherein the plurality of three-dimensional images and the at least one biomarker identified in the plurality of three-dimensional images are used to form a model of the joint and the at least one biomarker in three dimensions of space and one dimension of time.
- 8. The method of claim 7, wherein the biomarker is tracked over time in the model.
- 9. The method of claim 1, wherein a resolution in all three dimensions of the at least one three-dimensional image is finer than 1 mm.
- 10. The method of claim 9, wherein the at least one quantitative measurement comprises a higher order quantitative measurement.
- 11. The method of claim 10, wherein the higher order quantitative measurement comprises at least one of curvature, topology and shape.
- 12. The method of claim 1, wherein the at least one biomarker is selected from the group consisting of:
shape of a subchondral bone plate; layers of cartilage and their relative size; signal intensity distribution within the cartilage layers; contact area between articulating cartilage surfaces; surface topology of a cartilage shape; intensity of bone marrow edema; separation distances between bones; meniscus shape; meniscus surface area; meniscus contact area with cartilage; cartilage structural characteristics; cartilage surface characteristics; meniscus structural characteristics; meniscus surface characteristics; pannus structural characteristics; joint fluid characteristics; osteophyte characteristics; bone characteristics; lytic lesion characteristics; prosthesis contact characteristics; prosthesis wear; joint spacing characteristics; tibia medial cartilage volume; tibia lateral cartilage volume; femur cartilage volume; patella cartilage volume; tibia medial cartilage curvature; tibia lateral cartilage curvature; femur cartilage curvature; patella cartilage curvature; cartilage bending energy; subchondral bone plate curvature; subchondral bone plate bending energy; meniscus volume; osteophyte volume; cartilage T2 lesion volumes; bone marrow edema volume and number; synovial fluid volume; synovial thickening; subchondrial bone cyst volume; kinematic tibial translation; kinematic tibial rotation; kinematic tibial valcus; distance between vertebral bodies; degree of subsidence of cage; degree of lordosis by angle measurement; degree of off-set between vertebral bodies; femoral bone characteristics; and patella characteristics.
- 13. The method of claim 1, wherein step (a) is performed through magnetic resonance imaging.
- 14. A system for assessing a joint of a patient, the system comprising:
(a) an input device for receiving at least one three-dimensional image of the joint; (b) a processor, in communication with the input device, for receiving the at least one three-dimensional image of the joint, identifying at least one biomarker in the at least one three-dimensional image and deriving at least one quantitative measurement of the at least one biomarker; (c) storage, in communication with the processor, for storing the at least one three-dimensional image, an identification of the at least one biomarker and the at least one quantitative measurement; and (d) an output device for displaying the at least one three-dimensional image, the identification of the at least one biomarker and the at least one quantitative measurement.
- 15. The system of claim 14, wherein the storage also stores the at least one three-dimensional image.
- 16. The system of claim 14, wherein the processor identifies the at least one biomarker through statistical segmentation of the at least one three-dimensional image.
- 17. The system of claim 14, wherein the at least one three-dimensional image comprises a plurality of three-dimensional images of the joint taken over time.
- 18. The system of claim 17, wherein the processor identifies the at least one biomarkers through statistical segmentation of a three-dimensional image selected from the plurality of three-dimensional images.
- 19. The system of claim 18, wherein the processor uses motion tracking and estimation to identify the at least one biomarker in the plurality of three-dimensional images in accordance with the at least one biomarker identified in the selected three-dimensional image.
- 20. The system of claim 19, wherein the plurality of three-dimensional images and the at least one biomarker identified in the plurality of three-dimensional images are used to form a model of the joint and the at least one biomarker in three dimensions of space and one dimension of time.
- 21. The system of claim 14, wherein a resolution in all three dimensions of the at least one three-dimensional image is finer than 1 mm.
- 22. The system of claim 14, wherein the at least one quantitative measurement comprises a higher order quantitative measurement.
- 23. The system of claim 22, wherein the higher order quantitative measurement comprises at least one of curvature, topology and shape.
- 24. The system of claim 14, wherein the at least one biomarker is selected from the group consisting of:
shape of a subchondral bone plate; layers of cartilage and their relative size; signal intensity distribution within the cartilage layers; contact area between articulating cartilage surfaces; surface topology of a cartilage shape; intensity of bone marrow edema; separation distances between bones; meniscus shape; meniscus surface area; meniscus contact area with cartilage; cartilage structural characteristics; cartilage surface characteristics; meniscus structural characteristics; meniscus surface characteristics; pannus structural characteristics; joint fluid characteristics; osteophyte characteristics; bone characteristics; lytic lesion characteristics; prosthesis contact characteristics; prosthesis wear; joint spacing characteristics; tibia medial cartilage volume; tibia lateral cartilage volume; femur cartilage volume; patella cartilage volume; tibia medial cartilage curvature; tibia lateral cartilage curvature; femur cartilage curvature; patella cartilage curvature; cartilage bending energy; subchondral bone plate curvature; subchondral bone plate bending energy; meniscus volume; osteophyte volume; cartilage T2 lesion volumes; bone marrow edema volume and number; synovial fluid volume; synovial thickening; subchondrial bone cyst volume; kinematic tibial translation; kinematic tibial rotation; kinematic tibial valcus; distance between vertebral bodies; degree of subsidence of cage; degree of lordosis by angle measurement; degree of off-set between vertebral bodies; femoral bone characteristics; and patella characteristics.
REFERENCE TO RELATED APPLICATIONS
[0001] The present application claims the benefit of U.S. Provisional Application No. 60/307,869, filed Jul. 27, 2001, whose disclosure is hereby incorporated by reference in its entirety into the present disclosure.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60307869 |
Jul 2001 |
US |